Calvin Choi, MD, MS, FACC, FSCAI, discusses Chronic Total Occlusion Percutaneous Coronary Intervention (CTO PCI). He reviews pertinent data and shares indications for CTO PCI. He focuses on the factors that play into the decision to pursue CTO PCI and why proper patient selection is critical as he examines contemporary strategy and technique for CTO PCI.

Kenneth Cusi, MD, FACP, FACE, joins the show to help us to understand the mechanisms leading to NAFLD and the role of obesity and type 2 diabetes mellitus (T2DM). He shares the diagnostic difficulties regarding NAFLD and he reviews current treatment modalities and future developments in the field.

In this panel discussion, Ki Park M.D and Kirsten Freeman M.D define common cardiovascular diseases in women. They characterize when a disease process needs intervention and help us to recognize the differences when treating women with cardiovascular disease. They offer various treatment options for women that are diagnosed with cardiovascular disease.

Thomas Beaver, MD, MPH, and William Miles, MD, FACC, discuss hybrid treatment approaches for Atrial Fibrillation. They review the types of Atrial Fibrillation including Paroxysmal and Persistent. They share treatment approaches as they introduce hybrid ablation: combining catheter and minimally invasive surgery for Atrial Fibrillation.

Shawn Larson, MD, FACS, and Lauren Indelicato DNP, APRN, help us to recognize that pediatric trauma and burn injury is a significant public health issue. Listen in as they share the reasons why children require a specialized approach and adequate resources for burn injury. They discuss the principles of specialized pediatric burn management and they offer directions for future research and where important improvements can be made.

Saleem Islam, MD, MPH, and Janice Taylor, MD, discuss care for pediatric chest wall deformities - Pectus Excavatum and Pectus Carinatum. They help us understand the reasons why these occur, and how they present. They correlate the clinical symptoms with the deformity and potential long term issues and cover the treatment options available at UF Health Shands Hospital.

Zubin Agarwal, MD, helps us to understand how dysynchrony is measured. He defines the mechanism of action of resynchronization therapy and offers providers advice on how to recognize when a patient would benefit from referral for device therapy.

Maryam Rahman, MD, discusses the clinical indications for treatment of brain tumors with laser interstitial thermotherapy (LITT) and she examines the expected outcomes of LITT treated brain tumors. She shares how the development of complementary technologies, such as intraoperative magnetic resonance imaging (MRI) and real-time MRI thermometry have enabled LITT to enter the fields of neurosurgery and neuro-oncology.

In this panel, Christopher Harden, MD, and Gabrielle Graves, MD, discuss what we know about idiopathic pulmonary fibrosis. They share how we define it, and the prevalence. They examine what types of treatments are available and what the future holds for further research into IPF.

Brandon Allen, MD, discusses high-sensitivity troponin assays in the emergency department. Through this podcast, we will understand the evolution of Troponin from contemporary to high-sensitivity assays. We will identify key considerations for the implementation of high-sensitivity troponin and we will recognize future changes to rule out strategies and observation based on the implementation of high-sensitivity Troponin.